Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Master of Business Administration, University Of Kentucky
1999
Post Doctoral Fellow, Johns Hopkins University
1981
Residency, University Of Virginia
1979
Internship, West Virginia University
1976
Doctor of Medicine, West Virginia University
1975
Bachelor of Arts, Johns Hopkins University
1970
Fingerprint
Dive into the research topics where John Slevin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
A Pharmacokinetic Study of Lecigon Enteral Suspension in Subjects With Advanced Parkinson's Disease: A Randomized, Cross-Over Study to Investigate the Pharmacokinetics of Entacapone, Carbidopa, and Levodopa (Lecigon) Versus Carbidopa and Levodopa Entera
Slevin, J. (PI)
12/20/24 → 12/19/26
Project: Research project
-
Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients with Motor Complications
Slevin, J. (PI)
Pharmaceutical Research Associates
11/21/24 → 11/20/26
Project: Research project
-
Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimer's Disease
Gerhardt, G. (PI), Ali, S. (CoI), Jicha, G. (CoI), Kryscio, R. (CoI), Quintero, J. (CoI), Schmitt, F. (CoI), Slevin, J. (CoI) & van Horne, C. (CoI)
6/15/24 → 5/31/29
Project: Research project
-
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
BouNDless Study Group, May 2024, In: The Lancet Neurology. 23, 5, p. 465-476 12 p.Research output: Contribution to journal › Article › peer-review
29 Scopus citations -
Recipient Reaction and Composition of Autologous Sural Nerve Tissue Grafts into the Human Brain
Colvett, I., Gilmore, A., Guzman, S., Ledreux, A., Quintero, J. E., Ginjupally, D. R., Gurwell, J. A., Slevin, J. T., Guduru, Z., Gerhardt, G. A., van Horne, C. G. & Granholm, A. C., Oct 2023, In: Journal of Clinical Medicine. 12, 19, 6121.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Visualization of the Movement Disorder Society Unified Parkinson's Disease Rating Scale Results
Hixson, J., Quintero, J. E., Guiliani, A., Yamasaki, T. R., Gerhardt, G. A., Slevin, J. T. & Van Horne, C. G., May 9 2023, In: Journal of Parkinson's Disease. 13, 3, p. 421-426 6 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Direct delivery of an investigational cell therapy in patients with Parkinson's disease: An interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design
Quintero, J. E., Slevin, J. T., Gurwell, J. A., McLouth, C. J., El Khouli, R., Chau, M. J., Guduru, Z., Gerhardt, G. A. & Van Horne, C. G., Jul 1 2022, In: BMJ Neurology Open. 4, 2, e000301.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Encephalopathy and complex hyperkinesia in a patient with severe acute respiratory syndrome coronavirus-2 infection
Li, W., Coskun, E. P., Berger, R., Slevin, J. T. & Pettigrew, L. C., 2021, In: Journal of Movement Disorders. 14, 2, p. 173-175 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access